Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
ItalyStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
ItalyStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
ItalyStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
ItalyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
ItalyStudy of Elafibranor for Adults with Primary Biliary Cholangitis
ItalyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
ItalyLong-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine
ItalyStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
ItalyStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
ItalyStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
ItalyStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
